CD6 and Graves disease: Previous studies have indicated that miR-4442, which targets CD6, may be involved in Grave’s disease and Hashimoto’s thyroiditis [48] and in the proliferation or apoptosis in small airway epithelial cells exposed to transforming growth factor-β [49].